S

Sonoma Biotherapeutics

127 employees

Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2020

Funding rounds raised

Total raised

$265M

from 21 investors over 21 rounds

S

Sonoma Biotherapeutics raised $30M on March 28, 2023

Investors: Regeneron

S

Sonoma Biotherapeutics raised $265M on August 4, 2021

Investors: NS Investment, Lilly Asia Ventures, Octagon Capital, Piper Sandler, JDRF T1D Fund, Osage University Partners (OUP), Lifeforce Capital, Mirae Asset MAPS Global Investments Co., Ltd and Vertex Ventures HC

S

Sonoma Biotherapeutics raised $30M on September 30, 2020

Investors: Octagon Capital, Lilly Asia Ventures, Lyell Immunopharma, JDRF T1D Fund, Lifeforce Capital, 8VC and ARCH Venture Partners

S

Sonoma Biotherapeutics raised $40M on February 6, 2020

Investors: Lyell Immunopharma, 8VC, Milky Way Ventures and ARCH Venture Partners

FAQ